Nature of Disease: A sporadic, worldwide condition involving acute intravascular hemolysis.
Target Population: Primarily affects high-yielding individual dairy cows at the onset of lactation.
Key Risks: Characterized by potentially life-threatening anemia and hemoglobinuria.
Fatality Rate: Ranges from 10% to 30%.
Etiology and Pathogenesis (Possible Causes)
Primary Theory (Phosphorus): Phosphorus deficiency leads to the depletion of intracellular ATP in red blood cells (RBCs). This increases osmotic fragility, predisposing them to rupture.
The Phosphorus Paradox: While hypophosphatemia is a common lab result, it is not the sole cause, as many cows with low phosphorus do not develop the disease.
Copper Deficiency: Linked to cases in specific regions (e.g., New Zealand); it is thought to increase RBC susceptibility to oxidative stress.
Dietary Toxins: Excessive consumption of specific feeds like rapeseed, turnips, and sugar-beet pulp has been incriminated.
Antioxidant Deficiency: General lack of antioxidants may also contribute.
Clinical Findings
Early Phase: Often clinically inapparent until the Packed Cell Volume (PCV) drops below 20%.
General Signs: Rapid drop in milk production, anorexia, and lethargy.
Hemolytic Anemia Signs: Pale and icteric (jaundiced) mucous membranes, tachycardia, and tachypnea.
Urinary Signs:Hemoglobinuria, evidenced by dark brown or red urine.
Recovery: Spontaneous recovery can occur if hemolysis stops, but complete recovery may take several weeks.
Diagnosis
Diagnostic Markers: Recognition of dark urine and anemia during early lactation.
Urine Analysis: Hemoglobinuria is confirmed if urine fails to clear with centrifugation, distinguishing it from hematuria.
Blood Phosphorus Unreliability: Blood phosphorus levels are unreliable indicators for diagnosis because massive hemolysis releases intracellular phosphorus, which can make blood levels appear normal or even elevated.
Differential Diagnosis (Exclusions):
Babesiosis or Theileriosis: Excluded via blood smear analysis.
Leptospirosis or Bacillary Hemoglobinuria: Excluded via standard laboratory methods.
Treatment and Prevention
Emergency Intervention:Whole blood transfusion (4–6 L) is the only known effective treatment for severe cases where PCV is < 15%.
Supportive Care:
Provide a calm environment with easy access to feed and water.
Oral fluid drenches to maintain hydration.
Mineral Correction:
Phosphate Salts: Oral or IV administration can correct hypophosphatemia, but it does not stop the active hemolysis.
Copper Glycinate: Used for copper deficiency (considered extralabel use).
Prevention: Correct dietary mineral deficiencies (phosphorus and copper) and eliminate known toxic plants from the diet.